Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Pascal Thériault-Lauzier , Marco Spaziano , Beatriz Vaquerizo , et al Added: 3 years ago
Valvular Disease Aortic valve Severe symptomatic aortic stenosis (AS) bears a dismal prognosis. The mean survival is 2.0 to 4.7 years after the onset of angina, 0.8 to 3.8 years after the onset of syncope and 0.5 to 2.8 years after the onset of congestive heart failure.1 Surgical aortic valve replacement (SAVR) is the mainstay of treatment for these patients.2 In the last decade transcatheter… View more

Vascular Disease and Surgery

Imaging & Diagnostics
The Interventional Imaging Specialist
Author(s): Nina Wunderlich , Harald Küx , Felix Kreidel , et al Added: 3 years ago
Over the past 30 years, several percutaneous transcatheter technologies and devices for interventions in structural heart diseases (SHDs) have been introduced (see Table 1). There are numerous technologies that are in development or are currently being used to treat patients with SHD that use transcatheter techniques. The variety of percutaneous treatment approaches has led to a revolution and… View more

Vascular Disease and Surgery

Imaging & Diagnostics
Author(s): Jan Balzer , Tobias Zeus , Verena Veulemans , et al Added: 3 years ago
Percutaneous catheter-based structural heart disease procedures are a rapidly growing area of interventional cardiology, and represent a valuable option for cardiac patients with comorbidities who are ineligible for conventional surgery as well as demonstrating excellent outcomes.1,2 Catheter-based interventions include transcatheter aortic valve implantation (TAVI),3 percutaneous mitral valve … View more

Imaging & Diagnostics

Intervention
Steven Yakubov
Job title: Director
Dr Yakubov is the John H. McConnell Chair of Advanced Structural Heart Disease, System Medial Chief, Advanced Structural Heart Disease of OhioHealth and Medical Director of Cardiovascular Studies for the OhioHealth Research Institute at Riverside Methodist Hospital, Columbus, Ohio. He has been involved in numerous clinical trials to advance treatment options for cardiovascular disease and… View more
Robert Gooley
Research Area(s) / Expertise:
Personal History Dr Robert Gooley is a General, Interventional and Structural Cardiologist. He is married and enjoys traveling with his family. He is an avid runner and Hawks supporter.3, 4 Academic History In 2004, Dr Gooley got his MBBS from Monash University with first class honours and completed his physician training at Monash Health. He also completed his advanced training… View more
Job title: Director of the Center for Valve and Structural Heart Disease
Dr Paul Sorajja is an Interventional Cardiologist at the Minneapolis Heart Institute at Abbott Northwestern Hospital, where he is the Director of the Center for Valve and Structural Heart Disease. Dr Sorajja's clinical practice specialises in interventional cardiology, with a focus on catheter-based therapy of valvular and structural heart disease. He was part of the team that performed the… View more
TRILUMINATE Pivotal Trial Results
Author(s): Paul Sorajja , Ralph Stephan von Bardeleben , , et al Added: 1 year ago
In this short series of interviews, our faculty discuss the recent TRILUMINATE Pivotal Trial Results. We hear fromone of the lead PI’s on the trial,Dr Paul Sorajja (Abbott Northwestern Hospital, Minneapolis, US), as well as Cardiac Surgeon Dr Vinod Thourani (Piedmont Healthcare, Atlanta, US), Interventionalist Prof Ralph Stephan Von Bardeleben (Heart Valve Centre, Mainz, DE) and Heart… View more

Intervention
Research Area(s) / Expertise: Job title: MD
Dr O’Neill is the Medical Director of the Centre for Structural Heart Disease at Henry Ford Hospital, Detroit. He is an internationally recognised leader in interventional cardiology and structural heart disease, and a pioneer in research and new techniques to diagnose and treat heart disease. He has authored more than 300 peer-reviewed articles and was the founding member of the American Board… View more
RF
Author(s): Steven Yakubov , Andreas Schäfer , Richard Schatz , et al Start date: Sep 15, 2021

Heart Failure

MI/ACS